Cumulative revenue of 196.9 billion won and operating profit of 35.7 billion won; Eumseong plant utilization rate at 86.7%.
Craver Corporation revenue up 49%; Osong site secured with 51.6 billion won in investment capital available.
Hankook Cosmetics Manufacturing (003350), a specialist in cosmetics OEM and ODM, has surpassed its total annual performance from last year in just nine months, buoyed by the growth of the K-beauty market. As the company maintains its growth trajectory through expanded sales from key clients and high factory utilization, investment in a new facility in Osong is emerging as a critical variable for future expansion.
For the first nine months of this year, the company reported cumulative revenue of 196.9 billion won, a 34.3% increase year-on-year, while operating profit rose 24.7% to 35.7 billion won. These figures exceed the full-year revenue of 184.6 billion won and operating profit of 32.9 billion won recorded in the previous year.
Client Sales Growth Offset by Rising Cost Pressures
Third-quarter standalone revenue reached 73.5 billion won, up 34.1% year-on-year, with operating profit increasing 11.6% to 13.2 billion won. However, the operating profit margin declined from 21.6% to 18.0%.
The disparity between revenue growth and profit growth is attributed to rising cost burdens. The cost of sales ratio for the third quarter rose from 71.8% to 75.3%, with increasing prices for key raw materials cited as a primary factor weighing on profitability.
A major contributor to this growth is Craver Corporation, which operates the global cosmetics brand SKIN1004. Cumulative revenue from Craver Corporation for the first nine months reached 77.8 billion won, a 49.0% increase compared to the same period last year. Its share of total revenue grew from 35.6% to 39.5%.
Notably, growth is also diversifying. While standalone revenue from Craver Corporation grew by 9.3% in the third quarter, revenue from other clients surged by approximately 59%. While high reliance on a single client remains a risk, the expansion of business with other partners is a positive development.
Eumseong Plant Utilization at 86.7%; Osong Investment Strategy Key
Expansion of production capacity is also a focal point.
Hankook Cosmetics Manufacturing recorded a cumulative production output of 146.7 billion won for the first three quarters, with the Eumseong plant maintaining an average utilization rate of 86.7%.
In April, the company acquired approximately 17,499 square meters of industrial land in the Osong Bio-Polis District in Cheongju, North Chungcheong Province, for 6.46 billion won.
The company has also secured the necessary capital. It issued approximately 58.2 billion won in exchangeable bonds last October for facility and operational purposes, and as of the end of September, it holds approximately 51.6 billion won in unused funds, currently managed in time deposits.
However, the specific construction timeline and total investment amount for the new plant have yet to be finalized. The scale of future capital expenditure and the timing of production capacity expansion will be key variables in determining the company's growth potential.
While expectations for a recovery in the Chinese market are rising, Hankook Cosmetics Manufacturing's cumulative direct exports for the first nine months stood at approximately 2.4 billion won, accounting for only 1.2% of total revenue. Therefore, the company's growth is more dependent on the overseas sales expansion of domestic clients translating into increased manufacturing orders rather than direct exposure to the Chinese market.
The outlook hinges on whether the company can sustain the growth of OEM/ODM orders driven by global K-beauty brands, successfully translate the Osong investment into actual production capacity, and improve profitability by mitigating cost pressures.







